Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Pediatric Hematology/Oncology
Advanced Heart Failure and Transplant
Questions discussed in this category
Can CAR T cell therapy be considered for heart transplant recipients with concurrent lymphoproliferative disorders?
1 Answer available
16251
Papers discussed in this category
Pediatr Transplant, 2021 Aug
Treatment of post-transplant lymphoproliferative disorder (PTLD) in a heart transplant recipient with chimeric antigen receptor T-cell therapy.
Br J Haematol, 2023 May 2
Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
Bone marrow transplantation, 2022 Dec 27
CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic review.
Related Topics in Pediatric Hematology/Oncology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers